First large-scale international clinical programme for treatment of diabetic retinopathy
Wed, 01 Jun 2005 06:00 PM EST
... Takeda Pharmaceutical Company Limited announcedtoday that The Journal of the Renin-Angiotensin-Aldosterone System (JRAAS) has today published baseline data relating to the 5231 patients randomized into the major clinical trial programme, DIabetic REtinopathy Candesartan Trials (DIRECT)... click link for more info. ...
Related Topics
- Retinopathy
- Diabetic Foot
- Clinical Trials
- Psychopharmacology
- Diabetic retinopathy
- Diabetic Diet
- Diabetic Neuropathy
- International Health
- Neuropathy
- Depression
- Head and Brain Injuries
- Pharmacology
- Epidemiology
- Chemical Safety
- Asperger Syndrome
- Epidemiology & Prevention of Vaccine-Preventable Diseases
- Western/Clinical Treatment and Therapy
- Hypertensive retinopathy
- Clinical Growth Charts
- Brucellosis

Not Signed In -

